Understanding the molecular causes of Parkinson's disease

被引:231
|
作者
Wood-Kaczmar, A.
Gandhi, S.
Wood, N. W.
机构
[1] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
[2] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1016/j.molmed.2006.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a neurodegenerative disease that is both common and incurable. The majority of cases are sporadic and of unknown origin but several genes have been identified that, when mutated, give rise to rare, familial forms of the disease. The principal genes that have been shown to cause PD are alpha-synuclein (SNCA), parkin, leucine-rich repeat kinase 2 (LRRK2), PTEN-induced putative kinase 1 (PINK1) and DJ-1. Here, we discuss what has been learnt from the study of these genes and what has been elucidated of the molecular pathways that lead to cell degeneration. Of importance is what these molecular events and pathways tell scientists of the common sporadic form of PD. Although complete knowledge of these genes' functions remains elusive, recent work implicates abnormal protein accumulation, protein phosphorylation, mitochondrial dysfunction and oxidative stress as common pathways to PD pathogenesis.
引用
收藏
页码:521 / 528
页数:8
相关论文
共 50 条
  • [41] Molecular genetics of Parkinson's disease
    Bonifati, V
    Fabrizio, E
    Vanacore, N
    Meco, G
    GIORNALE DI NEUROPSICOFARMACOLOGIA, 1998, 20 (03): : 67 - 74
  • [42] Molecular pathogenesis of Parkinson's disease
    Gandhi, S
    Wood, NW
    HUMAN MOLECULAR GENETICS, 2005, 14 : 2749 - 2755
  • [43] Molecular chaperones and Parkinson's disease
    Hu, Shenglan
    Tan, Jieqiong
    Qin, Lixia
    Lv, Lingling
    Yan, Weiqian
    Zhang, Hainan
    Tang, BeiSha
    Wang, Chunyu
    NEUROBIOLOGY OF DISEASE, 2021, 160
  • [44] Molecular pathways to Parkinson’s disease
    Ming Guo
    Molecular Neurodegeneration, 7 (Suppl 1)
  • [45] Molecular pathogenesis of Parkinson's disease
    Gandhi, S
    Wood, NW
    HUMAN MOLECULAR GENETICS, 2005, 14 (18) : 2749 - 2755
  • [46] Understanding the links between cardiovascular disease and Parkinson's disease
    Potashkin, Judy
    Huang, Xuemei
    Becker, Claudia
    Chen, Honglei
    Foltynie, Thomas
    Marras, Connie
    MOVEMENT DISORDERS, 2020, 35 (01) : 55 - 74
  • [47] Punding in Parkinson's disease: To a better understanding of a common phenomenon between Parkinson's disease and addictions
    Tremey, A.
    de Chazeron, I.
    Brousse, G.
    Llorca, P. M.
    EUROPEAN PSYCHIATRY, 2016, 33 : S145 - S145
  • [48] UNDERSTANDING THE EARLY PATHOLOGICAL PATHWAYS IN PARKINSON'S DISEASE. THE OXFORD PARKINSON'S DISEASE CENTRE
    Hu, M.
    Ponting, C.
    Mackay, C.
    Talbot, K.
    Wade-Martins, R.
    Wood, M.
    Bolam, J. P.
    Ben-Shlomo, Y.
    Ansorge, O.
    James, W.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (11): : E59 - E59
  • [49] Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease
    Hattori, N
    Shimura, H
    Kubo, S
    Wang, M
    Shimizu, N
    Tanaka, K
    Mizuno, Y
    ADVANCES IN RESEARCH ON NEURODEGENERATION, VOL 8, 2000, 8 : 101 - 116
  • [50] Understanding the Molecular Aspects of Vitamins in Parkinson's Disease: Present-day Concepts and Perspectives
    Behl, Tapan
    Madaan, Piyush
    Sehgal, Aayush
    Makeen, Hafiz A.
    Albratty, Mohammed
    Alhazmi, Hassan A.
    Meraya, Abdulkarim M.
    Anwer, Md. Khalid
    Verma, Raman
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (19) : 1467 - 1485